FORM
FormFactor, Inc. Y
Valuation
Opportunity Score
W-IP Moat: W-IP
S-P7 Stack: S-P7
G-OPERATOR Governance: G-OPERATOR
M3 Methodology: M3
H-FORTRESS Fortress Balance Sheet
W-SCALE Economies of Scale
C2 Cycle: C2
T10 Tailwind: T10
T6 Tailwind: T6
AI-B AI: AI-B
RISK-3 INSIDER-EXIT: Aggressive Net Selling
T1 Tailwind: T1
CAT-1 AI-B: Advanced Packaging Expansion
RISK-4 FCF-MARGIN-STRESS: Low Cash Conversion
C1 Cycle: C1
RISK-1 V-OVERVALUED: Extreme Price-to-Target Divergence
RISK-2 EPS-DECEL: Structural Growth Deceleration
V-WIDE-MOAT Wide Moat
Overview
FormFactor manufactures high-performance test and measurement technologies, specifically probe cards and analytical probes used in the semiconductor manufacturing process. The company provides critical testing infrastructure for wafer-level validation of high-performance computing, mobile, and automotive integrated circuits.
Investment Thesis
While FormFactor remains integrated into the advanced packaging workflows necessary for high-performance AI silicon, the equity is currently trading at a massive disconnect from fundamental valuation. Although the company achieved 13.6% YoY revenue growth, the stock price of $123.73 has surged 42.4% beyond the analyst mean target of $86.89. This premium is difficult to justify as EPS growth is expected to decelerate from 89.9% in the current quarter to just 20.3% next fiscal year. Furthermore, the lack of cash conversion, evidenced by a thin 1.5% FCF margin, suggests that the revenue gains are being offset by high operational intensity, a reality reflected in the $9.86 million of aggressive insider selling recorded over the last six months.
🕵️ Insider Radar
| Date | Insider | Type | Value |
|---|---|---|---|
| 2026-03-18 | Sell | 178.8K | |
| 2026-03-18 | Sell | 523.2K | |
| 2026-03-18 | Sell | 271.1K | |
| 2026-03-06 | Sell | 313K | |
| 2026-02-25 | Sell | 230K |
🔭 Quarterly Summary
FormFactor (FORM) reported a revenue growth of 13.6% YoY and 6.2% sequentially, driven by its strategic position in advanced packaging (S-P7) and AI-related testing demand (AI-B). While the company maintained a gross margin of 42.2%, its FCF margin remains thin at 1.5%, indicating high operational or capital intensity. Management commentary highlights tailwinds from AI infrastructure (T1, T6) and cycle recovery (C1, C2), though the financial performance is currently trailing market valuation expectations.